IL17A and non-Hodgkin lymphoma: Generally, pro-inflammatory cytokine levels were stable across the NHL patients in the early post-transplant period, though a significant reduction in IL-17 at day 8 and day 14 post-AHSCT was noted when compared to pre-AHSCT samples.